As Greg said in the July 14 update, capital raising is off the cards until early next year. In the meantime, CXS will submit their NDA for multi TKI failure, and present data at ASH 2010, both of which should give the languishing SP a kick along. There may even be word on approval in Europe for T315I indication.
